Abstract
Systemic inflammation associated syndromes are linked to high mortality rates and remain a challenge in emergency medicine. The administration of lipopolysaccharide (LPS) mimics systemic inflammation in an experimental animal model that produces pro-inflammatory cytokines such as TNF-±, IL-1² and IL-6, in addition to changes in body temperature, such as fever and hypothermia, depending on…